Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jan-02-16 | Jan-03-15 | Dec-28-13 | Dec-29-12 | Dec-31-11 | Jan-01-11 | Jan-02-10 | Jan-03-09 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| CV | | | | | | 1,036.0 | | |
| AF | | | | | | 708.0 | | |
| NMD | | | | | | 380.0 | | |
| Other Countries | | | | | 348.0 | 318.0 | 279.8 | 269.3 |
| Other | | | | | 5,264.0 | 2,722.0 | 4,401.4 | 4,094.0 |
| Total revenues | 5,541.0 | 5,622.0 | 5,501.0 | 5,503.0 | 5,612.0 | 5,164.0 | 4,681.3 | 4,363.3 |
| Revenue growth [+] | -1.4% | 2.2% | 0.0% | -1.9% | 8.7% | 10.3% | 7.3% | 15.5% |
| Other Countries | | | | | 9.4% | 13.6% | 3.9% | |
| Cost of goods sold | 1,745.0 | 1,653.0 | 1,574.0 | 1,538.0 | 1,533.0 | 1,410.0 | 1,253.4 | 1,170.5 |
| Gross profit | 3,796.0 | 3,969.0 | 3,927.0 | 3,965.0 | 4,079.0 | 3,754.0 | 3,427.9 | 3,192.7 |
| Gross margin | 68.5% | 70.6% | 71.4% | 72.1% | 72.7% | 72.7% | 73.2% | 73.2% |
| Selling, general and administrative | 1,878.0 | 1,856.0 | 1,805.0 | 1,803.0 | 2,084.0 | 1,818.0 | 1,675.3 | 1,636.5 |
| Research and development | 676.0 | 692.0 | 691.0 | 676.0 | 705.0 | 631.0 | 559.8 | 531.8 |
| Other operating expenses | 77.0 | 33.0 | 34.0 | -5.0 | -43.0 | -16.0 | -27.9 | 254.8 |
| EBITDA [+] | 1,499.0 | 1,698.0 | 1,694.0 | 1,775.0 | 1,629.0 | 1,565.0 | 1,434.3 | 972.1 |
| EBITDA growth | -11.7% | 0.2% | -4.6% | 9.0% | 4.1% | 9.1% | 47.5% | -12.8% |
| EBITDA margin | 27.1% | 30.2% | 30.8% | 32.3% | 29.0% | 30.3% | 30.6% | 22.3% |
| Depreciation | 218.0 | 221.0 | 218.0 | 196.0 | 203.0 | 178.0 | 155.0 | 149.0 |
| EBITA | 1,281.0 | 1,477.0 | 1,476.0 | 1,579.0 | 1,426.0 | 1,387.0 | 1,279.3 | 823.0 |
| EBITA margin | 23.1% | 26.3% | 26.8% | 28.7% | 25.4% | 26.9% | 27.3% | 18.9% |
| Amortization of intangibles | 116.0 | 89.0 | 79.0 | 88.0 | 93.0 | 66.0 | 58.5 | 53.4 |
| EBIT [+] | 1,165.0 | 1,388.0 | 1,397.0 | 1,491.0 | 1,333.0 | 1,321.0 | 1,220.8 | 769.6 |
| EBIT growth | -16.1% | -0.6% | -6.3% | 11.9% | 0.9% | 8.2% | 58.6% | -16.1% |
| EBIT margin | 21.0% | 24.7% | 25.4% | 27.1% | 23.8% | 25.6% | 26.1% | 17.6% |
| Non-recurring items [+] | 135.0 | 237.0 | 346.0 | 391.0 | 218.0 | 45.0 | 107.7 | 114.6 |
| Asset impairment | 96.0 | 181.0 | 301.0 | 298.0 | 171.0 | 17.0 | 74.0 | 50.0 |
| Unusual expense | 39.0 | 56.0 | 45.0 | 93.0 | 47.0 | 28.0 | 33.8 | 64.6 |
| In-process research & development | | | | | | 12.0 | | 319.4 |
| Interest expense, net [+] | 100.0 | 80.0 | 76.0 | 68.0 | | | | |
| Interest expense | 103.0 | 85.0 | 81.0 | 73.0 | 70.0 | 67.0 | 45.6 | 72.6 |
| Interest income | 3.0 | 5.0 | 5.0 | 5.0 | | | | |
| Other income (expense), net | -2.0 | -3.0 | -191.0 | -27.0 | -26.0 | -1.0 | -10.1 | -1.7 |
| Pre-tax income | 928.0 | 1,068.0 | 784.0 | 1,005.0 | 1,019.0 | 1,208.0 | 1,057.4 | 580.8 |
| Income taxes | 62.0 | 113.0 | 92.0 | 253.0 | 193.0 | 301.0 | 280.2 | 227.8 |
| Tax rate | 6.7% | 10.6% | 11.7% | 25.2% | 18.9% | 24.9% | 26.5% | 39.2% |
| Minority interest | -14.0 | -47.0 | -31.0 | | | | | |
| Net income | 880.0 | 1,002.0 | 723.0 | 752.0 | 826.0 | 907.0 | 777.2 | 353.0 |
| Net margin | 15.9% | 17.8% | 13.1% | 13.7% | 14.7% | 17.6% | 16.6% | 8.1% |
| |
| Basic EPS [+] | $3.12 | $3.52 | $2.52 | $2.40 | $2.55 | $2.76 | $2.28 | $1.03 |
| Growth | -11.3% | 39.6% | 5.0% | -5.8% | -7.8% | 21.2% | 121.5% | -34.5% |
| Diluted EPS [+] | $3.07 | $3.46 | $2.49 | $2.39 | $2.53 | $2.74 | $2.26 | $1.01 |
| Growth | -11.1% | 39.0% | 4.2% | -5.4% | -8.0% | 21.6% | 123.6% | -33.8% |
| |
| Dividends per share [+] | $1.16 | $1.08 | $1.00 | $0.92 | $0.84 | | | |
| Growth | 7.4% | 8.0% | 8.7% | 9.5% | | | | |
| |
| Shares outstanding (basic) [+] | 282.2 | 285.0 | 287.0 | 313.3 | 324.3 | 328.2 | 340.9 | 342.9 |
| Growth | -1.0% | -0.7% | -8.4% | -3.4% | -1.2% | -3.7% | -0.6% | 0.2% |
| Shares outstanding (diluted) [+] | 286.3 | 289.7 | 290.6 | 314.8 | 327.1 | 330.5 | 344.4 | 349.7 |
| Growth | -1.2% | -0.3% | -7.7% | -3.8% | -1.0% | -4.0% | -1.5% | -0.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|